November 01, 2025
The generic drugs industry is expected to grow from USD 487.21 billion in 2024 to USD 816.75 billion by 2034, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, while Asia Pacific sees strong grow...
November 06, 2025
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
October 17, 2025
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to...
November 01, 2025
According to market projections, the generic pharmaceuticals sector is expected to grow from USD 424.98 billion in 2024 to USD 947.67 billion by 2034, reflecting a CAGR of 8.35%. The rise in patent expiration, increasing demand for cost-effective and...
November 04, 2025
According to market projections, the global generic pharmaceuticals contract manufacturing market, valued at USD 81.24 billion in 2025, is anticipated to reach USD 143.22 billion by 2035, growing at a CAGR of 5.85% over the next decade. Day by day, t...
November 01, 2025
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
November 01, 2025
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fas...
November 01, 2025
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
November 01, 2025
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development ...
October 29, 2025
According to market projections, the nucleic acid drugs sector is expected to grow from USD 47.59 million in 2024 to USD 286.13 million by 2034, reflecting a CAGR of 19.84%. The nucleic acid drugs market is expanding due to advances in delivery techn...
November 12, 2025
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing...
November 14, 2025
Projections indicate that, drugs industry is projected to rise from USD 1688.14 billion in 2025 to USD 3034.63 billion by 2035, reflecting a CAGR of 6.04% over the next decade. Around the world, an increasing geriatric patients with chronic condition...
November 27, 2025
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North Amer...
November 28, 2025
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kid...
October 15, 2025
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
November 01, 2025
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
November 20, 2025
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects...
November 05, 2025
Projections indicate that, the global anti-hypertensive drugs market will increase from USD 26.76 billion in 2025 to USD 39.2 billion by 2035, experiencing a CAGR of 3.89% over the next 10 years. Market growth is driven by the rising prevalence of hy...
October 24, 2025
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advant...
November 01, 2025
According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with stat...
November 01, 2025
Based on market forecasts, the global gastrointestinal drugs market, projected at USD 40.21 billion in 2024, is expected to reach USD 55.85 billion by 2034, growing at a CAGR of 3.34% over the forecast period. The gastrointestinal drugs market is gro...
December 12, 2025
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat ast...
November 01, 2025
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America ...
November 01, 2025
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% sh...
November 01, 2025
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of d...
November 28, 2025
According to market projections, the global 3D printed drugs market, valued at USD 131.25 million in 2025, is anticipated to reach USD 547.36 million by 2035, growing at a CAGR of 15.35% over the next decade. In 2024, North America led the 3D printed...
November 01, 2025
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 18.69 billion in 2024 to USD 29.31 billion by 2034, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage b...
October 30, 2025
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of feve...
November 01, 2025
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing e...
November 01, 2025
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital ...
November 01, 2025
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023,...
November 14, 2025
According to market projections, the diabetes drugs sector is expected to grow from USD 70.44 billion in 2024 to USD 134.73 billion by 2034, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabet...
October 28, 2025
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
October 24, 2025
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPP...
November 20, 2025
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as wel...
November 01, 2025
AI in clinical trials for drugs market is growing due to its use in clinical research to monitor and improve medication adherence. This is particularly through the use of applications, such as facial, digital biomarkers, and vocal expression. AI redu...
November 26, 2025
According to market projections, the global over-the-counter or OTC drugs market, valued at USD 142.27 billion in 2025, is anticipated to reach USD 268.32 billion by 2035, growing at a CAGR of 6.55% over the next decade. In 2024, North America led th...
November 01, 2025
The anesthesia drugs market size is calculated at $0.669 bn in 2025 is to hit $2.058 bn by 2034. The anesthesia drugs market is growing due to rising surgical procedures, advancements in anesthesia techniques, and increasing demand for outpatient sur...
November 01, 2025
Projections indicate that, the global anti-obesity drugs market will increase from USD 7.17 billion in 2024 to USD 78.46 billion by 2034, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, ...
November 01, 2025
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases o...
November 01, 2025
Projections indicate that, anti-inflammatory drugs industry is projected to rise from USD 122.32 billion in 2024 to USD 274.79 billion by 2034, reflecting a CAGR of 8.43% over the next decade. In 2024, North America led the anti-inflammatory drugs ma...
November 01, 2025
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophreni...
November 01, 2025
According to market projections, the global liver cancer drugs market, valued at USD 3.05 billion in 2024, is anticipated to reach USD 11.5 billion by 2034, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to tre...
November 17, 2025
Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAI...
November 01, 2025
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
November 01, 2025
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. ...
November 01, 2025
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
October 28, 2025
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
November 01, 2025
Market insights predict the global pediatric drugs industry will increase from USD 144.88 billion in 2024 to USD 458.09 billion by 2034, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesses, mana...
November 27, 2025
According to market projections, the global sinusitis drugs market, valued at USD 2.33 billion in 2025, is anticipated to reach USD 4.16 billion by 2035, growing at a CAGR of 5.96% over the next decade. The growing research activities and increasing ...
November 01, 2025
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
October 29, 2025
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
November 01, 2025
According to forecasts, the global age-related macular degeneration (AMD) drugs market will grow from USD 10.57 billion in 2024 to USD 29.04 billion by 2034, with an expected CAGR of 10.66%. Rising patient demand for a better quality of life is estim...
November 01, 2025
According to market projections, the GLP-1 drugs sector is expected to grow from USD 48.3 billion in 2024 to USD 121.13 billion by 2034, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes a...
November 01, 2025
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
November 01, 2025
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, w...
November 01, 2025
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
November 01, 2025
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
November 05, 2025
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health ...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com